Argent Biopharma (LSE:RGT) Beginning Cash Position : £3.38 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Argent Biopharma Beginning Cash Position?

Argent Biopharma's Beginning Cash Position for the quarter that ended in Jun. 2024 was £3.38 Mil.

Argent Biopharma's quarterly Beginning Cash Position declined from Jun. 2023 (£0.60 Mil) to Dec. 2023 (£0.13 Mil) but then increased from Dec. 2023 (£0.13 Mil) to Jun. 2024 (£3.38 Mil).

Argent Biopharma's annual Beginning Cash Position declined from Jun. 2022 (£3.10 Mil) to Jun. 2023 (£1.00 Mil) and declined from Jun. 2023 (£1.00 Mil) to Jun. 2024 (£0.13 Mil).

Argent Biopharma Beginning Cash Position Historical Data

The historical data trend for Argent Biopharma's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argent Biopharma Beginning Cash Position Chart

Argent Biopharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Beginning Cash Position

Get a 7-Day Free Trial

1.30

1.02

3.10

1.00

0.13

Argent Biopharma Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Beginning Cash Position	Get a 7-Day Free Trial															4.60	1.05	0.60	0.13	3.38

Argent Biopharma Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Argent Biopharma Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Argent Biopharma's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Argent Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Argent Biopharma Ltd (LSE:RGT) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

RGTLF:USA H5O0:Germany RGT:Australia

Address

295 Rokeby Road, Suite 1, Subiaco, WA, AUS, 6008

Website

https://www.argentbiopharma.com

Argent Biopharma Ltd is a drug discovery company that addresses unmet medical needs. The company focuses on multidisciplinary methods with nanotechnology, developing multi-target therapies for comprehensive disease management, especially in the central nervous system and immunology treatments. The products of the company include CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury, and ARDS, and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development, and others.